2023
DOI: 10.1016/j.autrev.2023.103311
|View full text |Cite
|
Sign up to set email alerts
|

Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 78 publications
0
2
0
Order By: Relevance
“…[1,2] The inflammatory response is redness, pain, swelling, and organ dysfunction. [3,4] Thus, controlling the development of inflammation processes as early as possible is a promising strategy for treatment IDs. However, traditional treatment is based on anti-inflammatory and immunosuppressive drugs, which are palliative and provide short-term relief with serious side effects.…”
Section: Introductionmentioning
confidence: 99%
“…[1,2] The inflammatory response is redness, pain, swelling, and organ dysfunction. [3,4] Thus, controlling the development of inflammation processes as early as possible is a promising strategy for treatment IDs. However, traditional treatment is based on anti-inflammatory and immunosuppressive drugs, which are palliative and provide short-term relief with serious side effects.…”
Section: Introductionmentioning
confidence: 99%
“…The pathogenic role of anti-cN1A in sIBM remains elusive, though lately attempts have been made to assess its impending pathogenicity [1]. How myopathy is also initiated in autoimmune rheumatic diseases and whether common pathophysiologic mechanisms do really exist are not yet clear [3][4][5][6]. Very recently, Yamashita et al [7] injected wild-type C57BL6 mice with three of the immunodominant cN1A peptides.…”
mentioning
confidence: 99%